Firm News

Wiggin and Dana Client CoRISMA MCS Systems Inc. Raises $27 Million in Series A Fundraising
On August 30, 2021, Wiggin and Dana represented its client CoRISMA MCS Systems Inc. (CoRISMA), a medical device company focused on implantable circulation systems for patients with heart conditions, in raising $27 million in its Series A Fundraising. The financing was led by China Grand Pharmaceutical (HKG:0512) and Healthcare Holdings Limited (Grand Pharma), which also entered into an agreement with CoRISMA for rights to develop and commercialize CoRISMA’s systems in Greater China and various other regions throughout Asia. Partners Toby Bannon, Jonathan Harris, Evan Kipperman, Counsel Elishama Rudolph, and Associate Daniel Nambiar were integral to the success of this transaction.
To read the official press release, please click here.